Free shipping over €250 · Tracked, discreet delivery in Europe

UU library

Every peptide, mapped to the body.

160 compounds, from approved medicines to early research molecules. Each one filed by the system research looks at, with its regulatory status and the strength of the evidence behind it.

Compounds
160
Research summaries
39
At UU
56
  • Approved medicine71

    Approved as a medicine by the FDA or the EMA for at least one indication. Approval covers the named indication and formulation only.

  • In clinical trials19

    In human clinical trials and not yet approved by the FDA or the EMA. Results to date are from trial populations under medical supervision.

  • Research compound53

    Not approved as a medicine by the FDA or the EMA. Some are registered in individual countries. Supplied for laboratory research only.

  • Cosmetic ingredient17

    Used as a topical cosmetic ingredient. Cosmetic use is not a medicinal approval, and most evidence comes from manufacturer and small panel studies.

Reviewed October 2026

In the UU catalog

Researched, batch-tested, ready to ship.

Compounds UU carries that have a full research summary in the library.

18 compounds · Sexual & reproductive

Sexual & reproductive18

Melanocortins, kisspeptin, oxytocin and the GnRH analogues of reproductive medicine.

Shop DESIRE
  • ApprovedAt UU

    Oxytocin

    Pitocin · Syntocinon

    Neurohypophyseal hormone

    The nine-residue hormone of labour and bonding. Approved to induce or support labour, and studied for social behaviour.

    Human trialsShop
  • ApprovedAt UU

    PT-141

    Bremelanotide · Vyleesi

    Melanocortin agonist

    A cyclic melanocortin agonist and a metabolite of Melanotan II. Approved by the FDA as bremelanotide for low sexual desire in premenopausal women.

    Human trialsShop
  • ResearchAt UU

    Kisspeptin-10

    Kisspeptin receptor agonist

    The shortest active fragment of kisspeptin, the upstream signal for GnRH. Studied in human physiology research on reproductive hormones.

    Early human dataShop
  • ResearchAt UU

    Prostamax

    Short bioregulator peptide

    A tetrapeptide associated with prostate tissue in Russian bioregulator research. Published evidence is limited.

    Summary pendingShop
  • ResearchAt UU

    Testagen

    Short bioregulator peptide

    A bioregulator peptide associated with testicular tissue in Russian research. Published evidence is limited.

    Summary pendingShop
  • ResearchAt UU

    Vesilute

    Short bioregulator peptide

    A dipeptide associated with bladder tissue in Russian bioregulator research. Published evidence is limited.

    Summary pendingShop
  • Approved

    Atosiban

    Tractocile

    Oxytocin receptor antagonist

    An oxytocin antagonist approved in Europe to delay imminent preterm birth.

    Summary pending
  • Approved

    Cetrorelix

    Cetrotide

    GnRH antagonist

    A GnRH antagonist approved to block premature ovulation during controlled ovarian stimulation in IVF.

    Summary pending
  • Approved

    Degarelix

    Firmagon

    GnRH antagonist

    A GnRH antagonist approved for advanced prostate cancer.

    Summary pending
  • Approved

    Ganirelix

    GnRH antagonist

    A GnRH antagonist approved to block the premature LH surge during IVF.

    Summary pending
  • Approved

    Gonadorelin

    GnRH · Factrel

    GnRH

    Synthetic gonadotropin-releasing hormone. Approved as a diagnostic agent for pituitary function.

    Summary pending
  • Approved

    Goserelin

    Zoladex

    GnRH agonist

    A GnRH agonist given as an implant. Approved for prostate cancer, breast cancer and endometriosis.

    Summary pending
  • Approved

    Histrelin

    Supprelin LA · Vantas

    GnRH agonist

    A GnRH agonist given as a yearly implant. Approved for central precocious puberty.

    Summary pending
  • Approved

    Human chorionic gonadotropin

    hCG · Pregnyl

    Glycoprotein hormone

    The pregnancy hormone, a glycoprotein that acts at LH receptors. Approved to trigger ovulation and for some forms of hypogonadism.

    Summary pending
  • Approved

    Leuprolide

    Leuprorelin · Lupron

    GnRH agonist

    A GnRH agonist approved for prostate cancer, endometriosis and central precocious puberty.

    Summary pending
  • Research

    Melanotan II

    MT-II

    Melanocortin agonist

    A cyclic, non-selective melanocortin agonist never approved as a medicine. Studied for pigmentation, and the parent compound of bremelanotide.

    Summary pending
  • Approved

    Nafarelin

    Synarel

    GnRH agonist

    A nasal GnRH agonist approved for endometriosis and central precocious puberty.

    Summary pending
  • Approved

    Triptorelin

    Trelstar · Decapeptyl

    GnRH agonist

    A GnRH agonist approved for advanced prostate cancer and, in some markets, other hormone-dependent conditions.

    Summary pending

The UU library is an educational reference. It is not medical advice, does not make a health claim, and does not tell anyone how to use a compound. UU products are sold for laboratory research use only and are not for human consumption. Regulatory status changes: confirm it with the relevant authority before relying on it.